Skip to main content

Posts

Showing posts with the label Thermo Fisher

Featured Post

Market Daily Report: Bursa Malaysia Closes Higher On BNM’s OPR Decision, Wall Street Gains

KUALA LUMPUR, Nov 5 (Bernama) -- Bursa Malaysia closed higher, buoyed by Bank Negara Malaysia’s (BNM) decision to maintain the Overnight Policy Rate (OPR) at 2.75 per cent, alongside positive cues from Wall Street. At 5 pm, the FTSE Bursa Malaysia KLCI (FBM KLCI) rose 19.30 points, or 1.19 per cent, to 1,635.86 from Wednesday’s close of 1,616.56. The benchmark index opened 6.72 points higher at 1,623.28, and fluctuated between an intraday high of 1,642.44 and a low of 1,622.62 during the trading session. However, market breadth was negative, with losers outnumbering gainers 723 to 497, while 466 counters were unchanged, 1,075 untraded and 10 suspended. Turnover rose to 3.74 billion units valued at RM3.61 billion compared with yesterday’s 2.81 billion units valued at RM2.57 billion.

Thermo Fisher (TMO) Surges 13% on Earnings Beat and Solid Outlook

Thermo Fisher Scientific (TMO)  jumped over  13% intraday , hitting  $487.93 , after posting a  strong Q2 earnings beat that reassured investors. Earnings Snapshot – Q2 2025 EPS (adjusted):  $5.36 (flat YoY)   > vs. $5.23 expected Revenue:  $10.85B (+3% YoY)   > beat by $173M Growth was fueled by: Life Sciences Solutions:  +6% YoY Lab Products & Biopharma Services:  +4% YoY However,  operating margins slipped  40bps to  21.9% , as  cost pressures  remain an ongoing concern. Analyst View (CFRA): TMO’s  diversified business model  and  key partnerships —like the expanded collaboration with  Sanofi —strengthen its positioning. Revenue outlook for 2025:  +1.9% YoY after a flat 2024. While macro uncertainty continues,  TMO’s leadership in core markets  could cushion external risks. Investor Takeaway: The beat was modest in numbers but  significant in sentiment —investors are res...